Abstract
Intracortical brain-computer interfaces (iBCI) have the potential to restore independence for individuals with significant motor or communication impairments. One of the most realistic avenues for clinical translation of iBCI technology is to enable control of a computer cursor—i.e. movement-related neural activity is interpreted (decoded) and used to drive cursor function. Both nonhuman primate and human studies have demonstrated high-level cursor translation control using attempted upper limb reaching movements. However, cursor click control—based on identifying attempted grasp—has only been successful in providing discrete click functionality; the ability to maintain click during translation does not yet exist. Here we present a novel decoding approach for cursor click based on identifying transient neural responses that emerge at the onset and offset of intended hand grasp. We demonstrate in a human participant, who used the BCI system independently in his home, that this transient-based approach provides high-functioning, generalized click control that can be used for both point-and-click and click-and-drag applications.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01894802
Funding Statement
Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Numbers UH3NS107714 and U01NS108922, Defense Advanced Research Projects Agency (DARPA) and Space and Naval Warfare Systems Center Pacific (SSC Pacific) under Contract N66001-16-C4051, and the UPMC Rehabilitation Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, DARPA, or SSC Pacific.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Pittsburgh IRB approved the study and it was conducted under an FDA Investigational Device Exemption
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data can be made available upon reasonable request.
